Arrakis Bio
Jerusalem, Israel· Est.
Industrial‑scale, sustainable production of human collagen for regenerative and aesthetic medicine.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Industrial‑scale, sustainable production of human collagen for regenerative and aesthetic medicine.
Regenerative MedicineAestheticsOrthopedics
Technology Platform
Cell‑cultivated human collagen production using metabolically engineered human cell lines and scalable bioprocessing with high‑purity extraction.
Opportunities
Rapidly expanding collagen market and growing demand for animal‑free, human‑derived biomaterials in aesthetics and regenerative therapies.
Risk Factors
Regulatory approval hurdles, scale‑up manufacturing challenges, and competition from established collagen suppliers.
Competitive Landscape
Competes with Geltor, CollPlant, and traditional animal‑derived collagen producers; differentiation lies in fully human, sustainably produced collagen at scale.